INNOVIVA, INC. Total Long-Term Debt
INNOVIVA, INC. (INVA) had Total Long-Term Debt of $739.13 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2016-08-04
- 2016-06-30: Long-term Debt $739.13M.
- 2016-03-31: Long-term Debt $748.95M.
- 2015-12-31: Long-term Debt $748.27M.
- 2014-12-31: Long-term Debt $725.64M.
| Period end | Long-term Debt |
|---|---|
| 2016-06-30 | $739.13M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $748.95M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $748.27M 10-Q · filed 2016-08-04 |
| 2014-12-31 | $725.64M 10-K · filed 2016-02-24 |
| 2013-12-31 | $287.50M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |